Development and Validation of Analytical HPLC Method for Identification and Assay of Enoxaparin Sodium in Injectable Preparations
Introduction. Enoxaparin sodium-containing drugs are included in relevant protocols for COVID-19 therapy. An increase in the production volume of such drugs leads to a demand for available and precise methods of identification and quantitative measurement of the active ingredient in the preparations...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-02-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Assuntos: | |
| Acceso en liña: | https://www.pharmjournal.ru/jour/article/view/1438 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|